Essay Focus 706 www.thelancet.com Vol 369 February 24, 2007 Acknowledgments Research undertaken for this paper was partly funded by grant number K12HD001438 from the US National Institutes of Health Oﬃ ces of Research on Women’s Health. References 1 Auton F. The advertising of pharmaceuticals direct to consumers: a critical review of the literature and debate. Int J Adver 2004; 23: 1–5. 2 Hone F, Benson R. DTC: European style. Pharm Exec 2004; 24: 96–102. 3 Kravitz RL, Epstein RM, Feldman MD, et al. Inﬂ uence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. JAMA 2005; 293: 1995–2002. 4 Angell M. The truth about the drug companies: how they deceive us and what to do about it. New York: Random House, 2004: 83. 5 Hollon M. Direct-to-consumer advertising: a haphazard approach to health promotion. JAMA 2005; 293: 2030–33. 6 Weissman JS, Blumenthal D, Silk AJ, Zapert K, Newman M, Leitman R. Consumers’ reports on the health e± ects of direct-to-consumer drug advertising. Health Af (Millwood) . Published online Feb 26, 2003. DOI:10.1377/hltha± .w3.82. 7 Metzl JM. Prozac on the couch: prescribing gender in the era of wonder drugs. Durham: Duke; 2003. 8 Aikin KJ. Direct-to-consumer advertising of prescription drugs: physician survey. Jan 13, 2003. http://www.fda.gov/cder/ddmac/ globalsummit2003/sld001.htm (accessed Feb 13, 2007). 9
This is the end of the preview. Sign up
access the rest of the document.
This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell.